Watch how Utah executes the art of ‘slipping’ in the pick and roll.
Watch how Utah executes the art of ‘slipping’ in the pick and roll.
The 35-year-old TV presenter used a 'Countdown' conundrum to reveal her happy news.
The "Global RegTech Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
The "Tours and Activities Reservations - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
The previously unseen video features the Beatle working on "Give Peace A Chance" days before the song was recorded.
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Alumina Ceramic Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Application" report has been added to ResearchAndMarkets.com's offering. According to this report the global alumina ceramic market was valued at US$ 4,428.90 million in 2019 and is projected to reach US$ 5,615.27 million by 2027; it is expected to grow at a CAGR of 3.5% from 2020 to 2027. The report highlights key factors driving the market growth and prominent players along with their developments in the market.Alumina ceramic is the most advanced engineering ceramic that provides outstanding electrical insulation properties combined with high hardness and good wear resistance, but with relatively low strength and fracture strength. Alumina ceramics are usually white but can also be pink (with 88% alumina) or brown (with 96% Alumina). High-purity alumina ceramics are ideal for environment where wear resistance and corrosive substances are necessary. It has superior thermal stability, which means that it is commonly used in areas where high-temperature tolerance is important. Alumina ceramic is a material of choice for the alumina wear components. Proven wear and a heat resistance of alumina wear parts make them suitable for the manufacturing of wear-resistant components.Alumina ceramic has high electrical insulation, acid and alkali corrosion resistance, and abrasion resistance. Advanced ceramics are used in a range of fields, including automotive and electronic equipment components. The products based on alumina ceramics such as ceramic bearings, mechanical seals, valves, and sensors are used in the automotive sector. For instance, Yttria Stabilized Zirconia - a ceramic material known for its high strength - is suitable for pump components such as fuel injectors and mechanical seals for engines requiring high durability. Further, alumina ceramics are cost-effective and durable than plastics and have found widespread use in the automotive industry, as advanced manufacturing technologies for car components need high-quality materials at an affordable cost. Moreover, ceramics can exhibit a variety of electrical properties, from insulators to resistors to semiconductors. Wide ceramic insulators that carry high-voltage electrical transmission wires are made of alumina. Ceramic insulators, such as alumina, are very strong heat conductors. They can be used as supporting material or as mounting brackets to which other electrical components are connected. For example, electronic devices in a modern car are placed on alumina. When the electronics unit runs, it produces heat, and the backrest of the alumina holds the heat away. This makes it possible for the electronic devices to work efficiently.BMW Steels Ltd.; Ceramtec; Dynamic Ceramic; Ferrotec Holdings Corporation; Kyocera Corporation; LSP Industrial Ceramics, Inc.; Morgan Advanced Materials; Saint Gobain S.A.; Sentro Tech; and Xiamen Innovacera Advanced Materials Co., Ltd. are among the well-established players operating in the global alumina ceramic market.Impact of COVID-19 Pandemic on Alumina Ceramic MarketThe COVID-19 outbreak was first reported in Wuhan (China) during December 2019. As of December 2020, the US, Brazil, India, Russia, Spain, and the UK are among the worst affected countries in terms confirmed cases and reported deaths. The outbreak is adversely affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Major industries across the world are suffering serious disruptions such as supply chain breaks, technology events cancellations, and office shutdowns. In addition, China is the global manufacturing hub and largest raw material supplier for various industries and it is also one of the worst affected countries. The lockdown of various plants and factories in China is restricting the global supply chains and disrupting the manufacturing activities, delivery schedules, and various materials sales. Various companies have already announced possible delays in product deliveries and slump in future sales of their products. Also, the global travel bans imposed by countries in Europe, Asia, and North America are hindering the business collaborations and partnerships opportunities. All these factors are restraining the growth of the alumina ceramic market. Reasons to Buy Highlights key business priorities in order to assist companies to realign their business strategies.The key findings and recommendations highlight crucial progressive industry trends in the global alumina ceramics market, thereby allowing players to develop effective long-term strategies.Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.Scrutinize in-depth the market trends and outlook coupled with the factors driving the market, as well as those hindering it.Enhance the decision-making process by understanding the strategies that underpin commercial interest `with respect to products, segmentation and industry verticals. Key Topics Covered: 1. Introduction1.1 Study Scope1.2 Research Report Guidance1.3 Market Segmentation2. Key Takeaways3. Research Methodology3.1 Scope of the Study3.2 Research Methodology3.2.1 Data Collection3.2.2 Primary Interviews3.2.3 Hypothesis formulation3.2.4 Macro-economic factor analysis3.2.5 Developing base number3.2.6 Data Triangulation3.2.7 Country level data4. Alumina Ceramics Market Landscape4.1 Market Overview4.2 PEST Analysis4.2.1 North America4.2.2 Europe4.2.3 APAC4.2.4 MEA4.2.5 SAM4.3 Expert Opinion5. Alumina Ceramics Market - Key Market Dynamics5.1 Market Drivers5.1.1 Growing Demand for Alumina Ceramic in Automotive and Medical Industries5.1.2 Environmental Friendliness and Reliability of Alumina Ceramics5.2 Market Restraint5.2.1 Higher Cost Than Metal and Other Alloys Counterparts5.3 Market Opportunities5.3.1 Rising Demand in Medical Industry5.4 Market Trends5.4.1 Increased Use as an Alternative to Metals and Plastics5.5 Impact Analysis of Drivers and Restraints6. Alumina Ceramics - Global Market Analysis6.1 Alumina Ceramics Market Overview6.2 Alumina Ceramics Market -Revenue and Forecast to 2027 (US$ Million)6.3 Market Positioning - Global Market Players7. Alumina Ceramics Market Analysis - By Application7.1 Overview7.2 Alumina Ceramics Market, By Application (2019 and 2027)7.3 Electronics and Semiconductors7.3.1 Overview7.3.2 Electronics and Semiconductors: Alumina Ceramics Market - Revenue and Forecast to 2027 (US$ Mn)7.4 Energy and Power7.4.1 Overview7.4.2 Energy and Power: Alumina Ceramics Market - Revenue and Forecast to 2027 (US$ Mn)7.5 Military and Defense7.5.1 Overview7.5.2 Military and Defense: Alumina Ceramics Market - Revenue and Forecast to 2027 (US$ Mn)7.6 Industrial7.6.1 Overview7.6.2 Industrial: Alumina Ceramics Market - Revenue and Forecast to 2027 (US$ Mn)7.7 Automotive7.7.1 Automotive: Alumina Ceramics Market - Revenue and Forecast to 2027 (US$ Mn)7.8 Medical7.8.1 Medical: Alumina Ceramics Market - Revenue and Forecast to 2027 (US$ Mn)7.9 Others7.9.1 Others: Alumina Ceramics Market - Revenue and Forecast to 2027 (US$ Mn)8. Alumina ceramic Market - Geographic Analysis8.1 Overview8.2 North America: Alumina ceramic Market8.3 Europe: Alumina ceramic Market8.4 Asia Pacific: Alumina ceramic market8.5 Middle East and Africa: Alumina ceramic Market8.6 South America: Alumina Ceramic Market9. Overview- Impact of COVID-199.1 North America: Impact Assessment of COVID-19 Pandemic9.2 Europe: Impact Assessment of COVID-19 Pandemic9.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic9.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic9.5 South America: Impact Assessment of COVID-19 Pandemic10. Industry Landscape10.1 Overview10.2 Strategy & Business Planning10.3 Merger and Acquisition11. Key Company Profiles11.1 Saint Gobain S.A.11.1.1 Key Facts11.1.2 Business Description11.1.3 Products and Service11.1.4 Financial Overview11.1.5 SWOT Analysis11.2 Xiamen Innovacera Advanced Materials Co., Ltd.11.2.1 Key Facts11.2.2 Business Description11.2.3 Products and Services11.2.4 Financial Overview11.2.5 SWOT Analysis11.3 Ceramtec11.3.1 Key Facts11.3.2 Business Description11.3.3 Products and Services11.3.4 Financial Overview11.3.5 SWOT Analysis11.4 Sentro Tech11.4.1 Key Facts11.4.2 Business Description11.4.3 Products and Services11.4.4 Financial Overview11.4.5 SWOT Analysis11.5 LSP Industrial Ceramics, Inc.11.5.1 Key Facts11.5.2 Business Description11.5.3 Products and Services11.5.4 Financial Overview11.5.5 SWOT Analysis11.6 Morgan Advanced Materials11.6.1 Key Facts11.6.2 Business Description11.6.3 Products and Services11.6.4 Financial Overview11.6.5 SWOT Analysis11.7 Kyocera Corporation11.7.1 Key Facts11.7.2 Business Description11.7.3 Products and Services11.7.4 Financial Overview11.7.5 SWOT Analysis11.8 Dynamic Ceramic11.8.1 Key Facts11.8.2 Business Description11.8.3 Products and Services11.8.4 Financial Overview11.8.5 SWOT Analysis11.9 BMW Steels Ltd.11.9.1 Key Facts11.9.2 Business Description11.9.3 Products and Services11.9.4 Financial Overview11.9.5 SWOT Analysis11.10 Ferrotech Holdings Corporation11.10.1 Key Facts11.10.2 Business Description11.10.3 Products and Services11.10.4 Financial Overview11.10.5 SWOT Analysis12. Appendix12.1 About the Publisher12.2 Glossary of TermsFor more information about this report visit https://www.researchandmarkets.com/r/v4gx1a CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The "Global Configure Price And Quote (CPQ) Software Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
'EasyJet is encouraged by the strong vaccination rollout in the UK and expects the European rollout to pick up pace in the coming weeks,' it said in a statement.
Novo Nordisk South Africa, an affiliate of the global healthcare company with more than 90 years of innovation and leadership in diabetes care, has been recently recognized as one of the best places to work in South Africa for 2021. The company received outstanding scores across several aspects of their workplace such as learning opportunities, organizational culture and giving back to the community resulting in its recognition among the employers of choice in South Africa.
The Daily Beast/Photo by Stefan Postles/GettyIn recent months, Australia—a country that weathered the pandemic far better than the United States, reporting fewer than 30,000 cases and 1,000 deaths—has struggled to get its citizens vaccinated, battling a deluge of sign-up glitches, shipment blockades, and devastating floods that forced more than 40,000 to evacuate their homes.Amid the strained rollout, the country has also had to contend with a different kind of hurdle: an erratic billionaire, described by the Western Australian premier as an “Olympic-scale narcissist,” whose political ambitions, immense resources, and faulty grasp of science have helped him drive an aggressive campaign to undermine public confidence in the shots.Clive Palmer, an Australian mining magnate who is worth an estimated $3.8 billion, according to Forbes, has spent the past few weeks disseminating anti-vaxx flyers and boosting misinformation about the COVID-19 vaccine across his home continent and in major national newspapers owned by Rupert Murdoch’s News Corp.“We started seeing about six weeks ago, Clive Palmer running ads in The Western Australian—which is the major newspaper here in Western Australia,” Member of Parliament Patrick Gorman, who has been publicly critical of Palmer’s anti-vaxx efforts, told The Daily Beast. “[These were] front-page ads, full-page, open letters, questioning the efficacy of vaccines generally, which would be costing him—per day—in the order of $20,000 or more.”Palmer‚ a man who once tried to build an exact replica of the Titanic called the “Titanic II,” only to abandon the ship before its maiden voyage, has a reputation in Australia as an antagonist of movie-villain proportions. In August, after the businessman filed a lawsuit against the Western Australian state government over mining contracts, a newspaper photoshopped his head onto Dr. Evil from Austin Powers, and ran it with the headline “$30 BIIIIILLION”—a reference to both the character’s catchphrase and the amount Palmer requested in damages. The next day they did it again; this time, Palmer’s head was on a cane toad. The headline read “PEST.”Their message may not have landed. On Sunday, the former member of parliament shared a graphic of the flyer on his Facebook page. Headlined “COVID-19 VACCINE CONCERNS” and addressed to “Men and Women of Australia,” the caution-tape yellow document outlined Palmer’s personal angst about the vaccine, even though he has no medical training of any kind.The signed statement—which also ran as a full-page ad in the Murdoch-owned paper, The Australian in March—included multiple falsehoods already debunked by the country’s Therapeutic Goods Administration (TGA). Most notably, Palmer referred to the Australian government’s “emergency use” approval of the vaccine on the general population. In fact, while other countries including the United States and the U.K. have protocols for “Emergency Use Authorizations”—a legal authority that allows them to distribute unapproved treatments when medically necessary—the TGA does not.There isn’t any special authorization the TGA granted the vaccines; they are still being reviewed through a six-stage process that is also applied to all other vaccines in the country. While the administration has committed to an expedited schedule, they say it does not involve skipping steps or relaxing standards. For that reason, only the Pfizer and AstraZeneca vaccines have been approved, and only for the first stage, which they call “provisional determination.”“The Therapeutic Goods Administration provisionally approved these vaccines after a complete assessment of all the available data,” the department wrote in a statement on its website. “No part of the process has been rushed, and there was no emergency authorisation granted. The TGA does not have an ‘Emergency Use Authorisation’ pathway for COVID-19 vaccines.” (The TGA, which did not respond to The Daily Beast’s request for comment, issued a warning last week against distributing the Astra-Zeneca vaccine to those under 50, because of two cases of blood clots).Elsewhere in the flyers, Palmer referred to two Australians who “became ill” after receiving an oversized dose of the Pfizer vaccine. While two patients did receive extra doses of the jab back in mid-February, they showed “no signs of an adverse reaction.” Australian Chief Medical Officer Paul Kelly told Australia 9News that early clinical trials of the Pfizer vaccine had experimented with larger doses of up to four times the current recommendation.“During those trials,” Kelly said, “the side effect profile was minimal, particularly in older people.” (Neither Palmer nor Kelly responded to The Daily Beast’s request for comment).“It made me really angry, to be honest,” Gorman said of the flyers, “because Clive Palmer is someone who has just tried to insert his way into national debates for his own business interests or because he has vendettas against various people.”As an example, Gorman pointed to Australia’s federal election in 2019, in which Palmer invested some $89 million of his own money campaigning. That is “far above what either major political party would spend in a national election,” Gorman said, “and his model of splashing cash to sort of boost his ego and put out misinformation at the worst possible time is unpatriotic.”The billionaire’s anti-vaxx promotional materials, of which there are several versions, have caught the attention of public officials as high as the prime minister. PM Scott Morrison attacked the messaging campaign last month as “complete rubbish,” and “misinformation, pure and simple.”The attacks marked something of an about-face for Morrison, who publicly backed a legal challenge from Palmer over the summer to Western Australia’s “hard border,” which had been closed to stymie the spread of COVID-19. The federal government later withdrew its support, which Gorman said had been poorly received by the Western Australian public, in part due to Palmer’s reputation. In response to the case, the state’s premier, McGowan, called Palmer “Australia’s greatest egomaniac.”Not long after, Shadow Health Minister Mark Butler flagged the flyers to the Australian Electoral Commission, urging the organization to investigate whether they should be considered political communications. Palmer, who served a single term in Parliament from 2013 to 2017 , formed a political party when he ran with a familiar slogan (“Make Australia Great”). He deregistered the party upon leaving office, but reactivated it in 2018, and continues to run candidates. Butler argued the flyers amounted to campaign materials and should be treated as “official party material.”“The COVID vaccine rollout and the government's response to the pandemic generally are very clearly going to be big election issues in the lead up to the 2021 or 2022 federal election," Butler told the Australian news organization, ABC News. "Clive Palmer, who is so closely associated with the party he began, is spewing misinformation in exactly the same way he runs an election campaign.” McGowan and Butler did not respond to The Daily Beast’s request for comment.Their accusations came just months after Palmer was charged with fraud and corporate misconduct over political advertisements for his party in July. Prosecutors accused Palmer of diverting some $10 million from his own businesses to the group (then called Palmer United) in 2013, which he would later use to foot the bill for a $60 million campaigning spree. If he is found guilty, the offenses could entail lengthy prison sentences.Dabbling in medical conspiracy is not a new development for Palmer; he has been waging a year-long misinformation campaign against the science and legality of Australia’s coronavirus response since the start of the pandemic. In March 2020, the billionaire announced plans to acquire or manufacture more than one million doses of hydroxychloroquine—the malaria treatment endorsed by President Trump as a COVID-19 cure, despite a total dearth of evidence that the drug has any impact on the disease.The lack of evidence did not bother Palmer. The next month he bought nearly 33 million doses of the drug to distribute for free among Australians. In an infographic published to his foundation’s website, titled “The COVID-19 Hydroxychloroquine Story,” he boasted of plans to make “resources available to fund clinical trials.” The next day, Palmer advertised the move with three full-page ads in prominent national newspapers—all of them owned by Murdoch’s News Corp.Why Is the Right So Obsessed With Hydroxychloroquine?Gratuitous use of hydroxychloroquine can pose a danger to patients who have not been prescribed the medication. The TGA has warned that the medication poses “well-known serious side-effects to patients, including cardiac toxicity potentially leading to sudden heart attacks, irreversible eye damage and severe depletion of blood sugar potentially leading to coma.” According to the Guardian, the TGA later opened an investigation into whether the ads breached their drug advertising rules.In 2021, Palmer’s faith in fast-tracked medical research seems to have waned, and he pivoted from boosting faulty drugs to questioning clinical studies. In the Australian outlet ABC News, the vice-president of the Australian Medical Association, Chris Moy, offered Palmer a suggestion: “Clive, we’ll leave the mining to you and you leave the medicine and the science to us.”“The problem is, say somebody doesn’t get the vaccination because of his message, which is clearly not based on any particular expertise on his part,” Moy added. “What happens if they later get COVID or even die later? He'll be completely removed from direct responsibility for it, but as far as I’m concerned, he’s as responsible as any doctor who does something wrong."Read more at The Daily Beast.Got a tip? Send it to The Daily Beast hereGet our top stories in your inbox every day. Sign up now!Daily Beast Membership: Beast Inside goes deeper on the stories that matter to you. Learn more.
The "Smart Utilities Management Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.
The "Beverage Flavoring Systems - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
People were seen using umbrellas to shield from tear gas used by law enforcement outside the Brooklyn Center Police Department in Minnesota on April 13, as protests over the death of Daunte Wright continued for a third consecutive night.Protests began in Brooklyn Center after a police officer fatally shot Wright during a traffic stop on April 11.Police Chief Tim Gannon described the shooting as an “accidental discharge”, saying to reporters that the officer in question drew a handgun instead of a Taser.This video from Samuel Doten shows a group of protesters use umbrellas as gas floats over them outside a security fence.Authorities said in a press conference on Wednesday that over 60 people had been arrested during the protest. Credit: Samuel Doten via Storyful
Rescuers have so far saved six of the commercial ship's reported 18 crew members from the water.
Vow ASA’s Annual General Meeting will be held on Friday 14 May at hrs. 09.00. The notice of the Annual General Meeting is enclosed and is also being sent to the company’s shareholders. For further queries, please contact:Erik Magelssen - CFO Tel: + 47 928 88 728 Email: firstname.lastname@example.org About Vow ASAIn Vow and our subsidiaries Scanship and Etia we are passionate about preventing pollution. Our advanced technology and world leading solutions purify wastewater and convert biomass and waste into valuable resources and generate clean energy for a wide range of industries, which as part of their own transition are looking for low carbon fuels, carbon neutral energy, decarbonised gas, and biocarbon. We have delivered technology to a wide range of industries for many years. Our solutions are scalable, standardized, patented, and thoroughly documented, and our capabilities are well proven in concrete projects and deliveries. In 2020, Vow established Vow Industries. This subsidiary will build, own, and operate plants that deliver industry decarbonisation as a service, thereby accelerating the green transition within waste and biomass valorisation and energy production. Located in Oslo, the parent company Vow ASA is listed on the Oslo Stock Exchange (ticker VOW). This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Attachment Vow ASA - Notice of AGM 2021
While most Japanese residents remain opposed to the Tokyo Games going ahead in 100 days' time, the International Olympic Committee hopes the mood will shift when people realise how much emphasis has been placed on minimizing the risk of COVID-19 infections. John Coates, the IOC's chief coordinator for Tokyo, also said stories of Japan's sporting success, such as Hideki Matsuyama's Masters triumph on Sunday, would boost support for the Games, which were postponed by a year due to the pandemic. With just over three months to go before the opening ceremony, organisers face a deluge of challenges with the pandemic affecting decisions on everything from athlete safety to spectator numbers to ticket sales as well as local public support for the Olympics.
Plus, how to get an additional discount.
Forecasts by Product Type (DNA Chip, Protein Chip, Enzyme Chip, Lab-on-a-Chip), Fabrication Techniques (Microarray, Microfluidics), Analysis Methods (Electrophoresis, Luminescence, Mass Spectrometry, Electrical Signals, Magnetism), Applications (Molecular Analysis, Diagnostics, Non-Biological Usage), End-use (Biotech & Pharma, Hospitals & Diagnostics Centers, Academic & Research Institutes, Others), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biochips Market Report 2020-2030" - https://www.reportlinker.com/p06058468/?utm_source=GNW PLUS Profiles of Leading Biochips Companies and COVID-19 Impact AnalysisBiochips–our new study reveals trends, R&D progress, and predicted revenues Where is the Biochips market heading? If you are involved in this sector you must read this newly updated report. This report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there. Discover how to stay ahead Our 380+ page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biochips Market. See how to exploit the opportunities. Forecasts to 2030 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, product profiles and commercial developments. This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today. Discover sales predictions for the world market and submarkets By Product Type • DNA Chip • Protein Chip • Enzyme Chip • Lab-on-a-Chip By Fabrication Techniques • Microarray • Microfluidics By Analysis Methods • Luminescence • Electrophoresis • Electrical Signals • Mass Spectrometry • Magnetism By Applications • Diagnostics • Molecular Analysis • Non-Biological Usage By End-Use • Biotech & Pharma • Hospitals & Diagnostics Centers • Academic & Research Institutes • Others By Region • North America – U.S. – Canada • Europe – Germany – France – UK – Italy – Spain – Rest of Europe • Asia Pacific – China – Japan – India – Rest of Asia Pacific • Latin America – Brazil – Mexico – Rest of Latin America • Middle East & Africa – GCC – South Africa – Rest of Middle East & Africa There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, U.S., Germany, UK and India, China in particular, will continue to achieve high revenue growth to 2030. Leading companies and the potential for market growth Overall world revenue for Biochips Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead. How the Biochips Market report helps you In summary, our 380+ page report provides you with the following knowledge: • Revenue forecasts to 2030 for Biochips Market, with forecasts for Product Type, Fabrication Techniques, Analysis Methods, Applications, End-Use, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues • Revenue forecasts to 2030 for 5 regional and 14 key national markets – See forecasts for the Biochips market in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. • Prospects for established firms and those seeking to enter the market– including company profiles for 9 of the major companies involved in the Biochips Market. Some of the company’s profiles in this report include Illumina, Inc., Agilent Technologies, Danaher Corporation, Fluidigm Corporation, Perkin Elmer, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KgaA, and Cellix, Ltd. Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence. Information found nowhere else With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the Biochips Market and leading companies. You will find data, trends and predictions.Read the full report: https://www.reportlinker.com/p06058468/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
The "Global Personal Safety Tracking Devices Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
The presenter shared a ‘teatime teaser’ on her social media accounts.
The European Commission plans to borrow around 150 billion euros annually until 2026 to finance the bloc's unprecedented plan to make its economy greener and more digitalised, making it the biggest issuer in euros, a document from the Commission showed. The financing for the EU economic plan, agreed at 750 billion euros in 2018 prices, but totalling around 800 billion euros at current prices, would be through auctions and syndication through a primary deal network to enable regular payouts to EU governments as they complete agreed stages of projects and reforms. The Commission document said the EU executive arm would issue bonds with benchmark maturities of 3, 5, 7, 10, 15, 20, 25 and 30 years and bills below one year maturity – EU-Bills.